Funding for this research was provided by:
Provincial Natural Science Foundation of Hunan (S2022JJMSXM3207)
Advanced Lung Cancer Targeted Therapy Research Foundation of China (CTONG-YC20210303)
CSCO-Hengrui Cancer Research Foundation (Y-HR2019-0185)
Article History
Received: 31 January 2023
Accepted: 25 March 2023
First Online: 5 April 2023
Declarations
:
: Not applicable.
: Not applicable.
: The authors declare no competing interests.